Frequently Asked Questions about Genflow Biosciences plc (GENF.L)

Name: Genflow Biosciences plc (GENF.L) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Genflow Biosciences plc (GENF.L) do?

Accepted Answer

Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-100...

Question 2

Is Genflow Biosciences plc (GENF.L) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of GENF.L reveals an Altman Z-Score of -27.76 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if GENF.L fits their risk profile.

Question 3

What is the current P/E ratio for GENF.L?

Accepted Answer

As of the latest trading session, Genflow Biosciences plc (GENF.L) has a trailing P/E ratio of -5.91.

Question 4

Who is the CEO of Genflow Biosciences plc?

Accepted Answer

The current Chief Executive Officer of Genflow Biosciences plc is Eric Jean Leire.

Question 5

What was GENF.L's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Genflow Biosciences plc reported annual revenues of $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021), $0.00B (2021) respectively.

Question 6

Does GENF.L pay a dividend?

Accepted Answer

Genflow Biosciences plc does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does GENF.L have?

Accepted Answer

In its latest reporting period, Genflow Biosciences plc generated $-0.00B in Free Cash Flow against a total debt load of $N/A.

Question 8

What is the Price-to-Book (P/B) ratio of Genflow Biosciences plc?

Accepted Answer

The Price-to-Book (P/B) ratio for Genflow Biosciences plc (GENF.L) is currently -24.75.

Question 9

What is the Price-to-Sales (P/S) ratio of GENF.L?

Accepted Answer

Based on trailing twelve-month data, Genflow Biosciences plc (GENF.L) trades at a Price-to-Sales (P/S) ratio of -69.20.

Question 10

What is Genflow Biosciences plc's Return on Equity (ROE)?

Accepted Answer

Genflow Biosciences plc (GENF.L) has a Return on Equity (ROE) of 377.33%, representing its profitability relative to shareholder equity.

GENF.L

UK IPO market limps through Q1 with just two listings as geopolitical strain and AI sell-off bite

Rezolve AI launches hostile takeover bid for Commerce.com

Genflow reports sustained safety and efficacy three months after gene therapy dosing in dog trial

Delta Air Lines shares take flight on first quarter earnings beat

February jobs shock signals slowing economy: analysts

Genflow Biosciences raises £800,000 to fund gene therapy programmes